Vir Biotechnology, Inc. Q1 FY2025 Earnings Call

Vir Biotechnology, Inc. (VIR)

Earnings Call FY2025 Q1 Call date: 2025-05-27 Concluded

Quarter scorecard

Revenue

$3.03M

-94.6% YoY

Diluted EPS

$-0.88

Net income

-$120.97M

Other Revenue $1.86M

Grant $1.24M

-76.1%

License and Collaboration Revenue -$70,000